Martin Kobel - Publications

The KPROCS Study: A Real-World and Research Resource to Investigate Multilevel Determinants of Ovarian Cancer Treatment and Survival.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: May 25, 2026

The real-world utility of homologous repair deficiency testing in BRCA1/2 wild-type high-grade serous carcinoma and the utility of MYC amplification as a potential surrogate marker.

Journal: Gynecologic oncology

Published: May 12, 2026

Serous Ovarian Cancer Following Opportunistic Bilateral Salpingectomy.

Journal: JAMA network open

Published: February 02, 2026

Lymph node involvement, surgery and adjuvant treatment in primary Endometrioid Ovarian carcinoma PAtients with eaRly-stage Disease (LEOPARD) - a multinational team initiative.

Journal: Gynecologic oncology

Published: February 01, 2026

Differential Preclinical Efficacy of Combined CDK4/6 and MEK Inhibition in Low-Grade Serous Ovarian Carcinoma Based on KRAS/NF1 Mutational Status.

Journal: International journal of molecular sciences

Published: December 13, 2025

Dedifferentiation in endometrial cancer is associated with HLA-I silencing that may be restored by IFN-γ.

Journal: The Journal of pathology

Published: November 25, 2025

Differences in overall survival for invasive epithelial ovarian cancer by race and ethnicity: results from the Ovarian Cancer Association Consortium.

Journal: British journal of cancer

Published: November 24, 2025

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Journal: Research square

Published: November 19, 2025

Identifying therapeutic targets in low-grade serous ovarian carcinomas with no specific molecular profile.

Journal: The Journal of pathology

Published: October 28, 2025

Human papilloma virus infection and mismatch repair protein expression in sebaceous neoplasms of the genital area.

Journal: Histopathology

Published: October 26, 2025

Context is key: how diagnostic and prognostic markers are reshaping gynecologic pathology.

Journal: The journal of pathology. Clinical research

Published: October 15, 2025

GREB1-rearranged uterine tumour shares a common DNA methylation signature with ESR1-rearranged UTROSCT.

Journal: Histopathology

Published: October 13, 2025